The oral microbiome of early stage Parkinson’s disease and its relationship with functional measures of motor and non-motor function
Open accessThe DOI matches its Crossref record; 76 of the 76 references it cites were found in a registry or an index.
Abstract
Changes in the function and microbiome of the upper and lower gastrointestinal tract have been documented in Parkinson's disease (PD), although most studies have examined merely fecal microbiome profiles and patients with advanced disease states. In the present study we sought to identify sensitive and specific biomarkers of changes in the oral microbiome of early stage PD through shotgun metatranscriptomic profiling. We recruited 48 PD subjects and 36 age- and gender-matched healthy controls. Subjects completed detailed assessments of motor, cognitive, balance, autonomic and chemosensory (smell and taste) functions to determine their disease stage. We also obtained a saliva sample for profiling of microbial RNA and host mRNA using next generation sequencing. We found no differences in overall alpha and beta diversity between subject groups. However, changes in specific microbial taxa were observed, including primarily bacteria, but also yeast and phage. Nearly half of our findings were consistent with prior studies in the field obtained through profiling of fecal samples, with others representing highly novel candidates for detection of early stage PD. Testing of the diagnostic utility of the microbiome data revealed potentially robust performance with as few as 11 taxonomic features achieving a cross-validated area under the ROC curve of 0.90 and overall accuracy of 84.5%. Bioinformatic analysis of 167 different metabolic pathways supported shifts in a small set of distinct pathways involved in amino acid and energy metabolism among the organisms comprising the oral microbiome. In parallel with the microbial analysis, we also examined the evidence for changes in human salivary mRNAs in the same subjects. This revealed significant changes in a set of 9 host mRNAs, several of which mapped to various brain functions and showed correlations with some of the significantly changed microbial taxa. Unexpectedly, we also observed robust correlations between many of the microbiota and functional measures, including those reflecting cognition, balance, and disease duration. These results suggest that the oral microbiome may represent a highly-accessible and informative microenvironment that offers new insights in the pathophysiology of early stage PD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Concerning PD, oral features associated with the disease such as dysphagia, salivary pH and drooling may influence the oral microbiota by altering the β-diversity index and favoring the growth of opportunistic oral microbes and Lactobacillus species, which may exacerbate the clinical symptoms and correlate with worse Hamilton Anxiety Scale and Hamilton Depression Rating Scale scores [70,496,497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“There was a strong correlation between the alterations in oral-specific microbial taxa and functional indexes in patients with Parkinson's disease.48”
From The role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options (2021) · cites this paper as [48]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Because of dysbiosis, the aminoacidic and energetic metabolisms associated with oral bacteria vary [497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
The cited source says what the claim attributes to it.
In the citing paper
“For example, the combination of 11 taxonomic features associated with the oral microbiota has allowed PD diagnosis reaching up to 84.5% accuracy, but better performances are expected to come [497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
In the citing paper
“Of note, these alterations can modulate the expression of salivary host mRNAs involved in multiple brain activities, thus supporting the relationship between oral microbiota and cognitive disorders [497].”
From The Interplay between Gut Microbiota and Parkinson’s Disease: Implications on Diagnosis and Treatment (2022) · cites this paper as [497]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653
Kalia, L. V., & Lang, A. E. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61393-3 · Cited by 6,184
Role of Streptococcus mutans in human dental decay
Loesche, W. J. (1986) · Microbiological Reviews · doi:10.1128/mr.50.4.353-380.1986 · Cited by 6,171
Mind-altering microorganisms: the impact of the gut microbiota on brain and behaviour
Cryan, J. F., & Dinan, T. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3346 · Cited by 4,572
Bravo, J. A., Forsythe, P., Chew, M. V., Escaravage, E., Savignac, H. M., Dinan, T. G., Bienenstock, J., & Cryan, J. F. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1102999108 · Cited by 3,888
Goetz, C. G., Poewe, W., Rascol, O., Sampaio, C., Stebbins, G. T., Counsell, C., Giladi, N., Holloway, R. G., Moore, C. G., Wenning, G. K., et al. (2004) · Movement Disorders · doi:10.1002/mds.20213 · Cited by 2,347
Serotonin, tryptophan metabolism and the brain-gut-microbiome axis
O’Mahony, S. M., Clarke, G., Borre, Y. E., Dinan, T. G., & Cryan, J. F. (2015) · Behavioural Brain Research · doi:10.1016/j.bbr.2014.07.027 · Cited by 2,012
Gut microbiota are related to Parkinson's disease and clinical phenotype
Scheperjans, F., Aho, V., Pereira, P. A. B., Koskinen, K., Paulin, L., Pekkonen, E., Haapaniemi, E., Kaakkola, S., Eerola‐Rautio, J., Pohja, M., et al. (2015) · Movement Disorders · doi:10.1002/mds.26069 · Cited by 1,968
Dhariwal, A., Chong, J., Habib, S., King, I. L., Agellon, L. B., & Xia, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx295 · Cited by 1,885
α-Synuclein Promotes SNARE-Complex Assembly in Vivo and in Vitro
Burré, J., Sharma, M., Tsetsenis, T., Buchman, V., Etherton, M. R., & Südhof, T. C. (2010) · Science · doi:10.1126/science.1195227 · Cited by 1,812
Using MetaboAnalyst 3.0 for Comprehensive Metabolomics Data Analysis
Xia, J., & Wishart, D. S. (2016) · Current Protocols in Bioinformatics · doi:10.1002/cpbi.11 · Cited by 1,544
Braak, H., de Vos, R. A. I., Bohl, J., & Del Tredici, K. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2005.11.012 · Cited by 1,354
Messaoudi, M., Lalonde, R., Violle, N., Javelot, H., Desor, D., Nejdi, A., Bisson, J.-F., Rougeot, C., Pichelin, M., Cazaubiel, M., et al. (2011) · British Journal of Nutrition · doi:10.1017/s0007114510004319 · Cited by 1,324
Colonic bacterial composition in Parkinson's disease
Keshavarzian, A., Green, S. J., Engen, P. A., Voigt, R. M., Naqib, A., Forsyth, C. B., Mutlu, E., & Shannon, K. M. (2015) · Movement Disorders · doi:10.1002/mds.26307 · Cited by 1,281
Vision assessment using the NIH Toolbox
Varma, R., McKean-Cowdin, R., Vitale, S., Slotkin, J., & Hays, R. D. (2013) · Neurology · doi:10.1212/wnl.0b013e3182876e0a · Cited by 1,178
Unger, M. M., Spiegel, J., Dillmann, K.-U., Grundmann, D., Philippeit, H., Bürmann, J., Faßbender, K., Schwiertz, A., & Schäfer, K.-H. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.08.019 · Cited by 1,159
Microorganisms with Claimed Probiotic Properties: An Overview of Recent Literature
Fijan, S. (2014) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph110504745 · Cited by 1,059
Forsyth, C. B., Shannon, K. M., Kordower, J. H., Voigt, R. M., Shaikh, M., Jaglin, J. A., Estes, J. D., Dodiya, H. B., & Keshavarzian, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028032 · Cited by 974
Hill‐Burns, E. M., Debelius, J. W., Morton, J. T., Wissemann, W. T., Lewis, M. R., Wallen, Z. D., Peddada, S. D., Factor, S. A., Molho, E., Zabetian, C. P., et al. (2017) · Movement Disorders · doi:10.1002/mds.26942 · Cited by 874
Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT
Visser, M., Marinus, J., Stiggelbout, A. M., & Van Hilten, J. J. (2004) · Movement Disorders · doi:10.1002/mds.20153 · Cited by 831
Meta‐analysis of early nonmotor features and risk factors for Parkinson disease
Noyce, A. J., Bestwick, J. P., Silveira‐Moriyama, L., Hawkes, C. H., Giovannoni, G., Lees, A. J., & Schrag, A. (2012) · Annals of Neurology · doi:10.1002/ana.23687 · Cited by 778
Bedarf, J. R., Hildebrand, F., Coelho, L. P., Sunagawa, S., Bahram, M., Goeser, F., Bork, P., & Wüllner, U. (2017) · Genome Medicine · doi:10.1186/s13073-017-0428-y · Cited by 642
Braak, H., Bohl, J. R., Müller, C. M., Rüb, U., de Vos, R. A. I., & Del Tredici, K. (2006) · Movement Disorders · doi:10.1002/mds.21065 · Cited by 630
Pathogenesis of Parkinson disease—the gut–brain axis and environmental factors
Klingelhoefer, L., & Reichmann, H. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2015.197 · Cited by 598
Brain-Gut-Microbiota Axis in Parkinson’s Disease
Mulak, A. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i37.10609 · Cited by 583
Martinez‐Martin, P., Schapira, A. H. V., Stocchi, F., Sethi, K., Odin, P., MacPhee, G., Brown, R. G., Naidu, Y., Clayton, L., Abe, K., et al. (2007) · Movement Disorders · doi:10.1002/mds.21586 · Cited by 554
The α‐Synucleinopathies: Parkinson's Disease, Dementia with Lewy Bodies, and Multiple System Atrophy
SPILLANTINI, M. G., & GOEDERT, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06900.x · Cited by 523
Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease
Hasegawa, S., Goto, S., Tsuji, H., Okuno, T., Asahara, T., Nomoto, K., Shibata, A., Fujisawa, Y., Minato, T., Okamoto, A., et al. (2015) · PLOS ONE · doi:10.1371/journal.pone.0142164 · Cited by 523
Analysis of Gut Microbiota in Patients with Parkinson’s Disease
Petrov, V. A., Saltykova, I. V., Zhukova, I. A., Alifirova, V. M., Zhukova, N. G., Dorofeeva, Y. B., Tyakht, A. V., Kovarsky, B. A., Alekseev, D. G., Kostryukova, E. S., et al. (2017) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-017-3700-7 · Cited by 487
Li, W., Wu, X., Hu, X., Wang, T., Liang, S., Duan, Y., Jin, F., & Qin, B. (2017) · Science China Life Sciences · doi:10.1007/s11427-016-9001-4 · Cited by 406
Parkinson's disease severity levels and MDS-Unified Parkinson's Disease Rating Scale
Martínez-Martín, P., Rodríguez-Blázquez, C., Alvarez, M., Arakaki, T., Arillo, V. C., Chaná, P., Fernández, W., Garretto, N., Martínez-Castrillo, J. C., Rodríguez-Violante, M., et al. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2014.10.026 · Cited by 360
Genomic investigation of α‐synuclein multiplication and parkinsonism
Ross, O. A., Braithwaite, A. T., Skipper, L. M., Kachergus, J., Hulihan, M. M., Middleton, F. A., Nishioka, K., Fuchs, J., Gasser, T., Maraganore, D. M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21380 · Cited by 342
Self-citationKunze, W. A., Mao, Y., Wang, B., Huizinga, J. D., Ma, X., Forsythe, P., & Bienenstock, J. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00686.x · Cited by 328
Like prions: the propagation of aggregated tau and α-synuclein in neurodegeneration
Goedert, M., Masuda-Suzukake, M., & Falcon, B. (2017) · Brain · doi:10.1093/brain/aww230 · Cited by 323
Gut microbiota in Parkinson disease in a northern German cohort
Hopfner, F., Künstner, A., Müller, S. H., Künzel, S., Zeuner, K. E., Margraf, N. G., Deuschl, G., Baines, J. F., & Kuhlenbäumer, G. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.019 · Cited by 318
Changes of colonic bacterial composition in Parkinson's disease and other neurodegenerative diseases
Gerhardt, S., & Mohajeri, M. H. (2018) · Nutrients · doi:10.3390/nu10060708 · Cited by 298
Role of Gardnerella vaginalis in the Pathogenesis of Bacterial Vaginosis: A Conceptual Model
Schwebke, J. R., Muzny, C. A., & Josey, W. E. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu089 · Cited by 261
Neurobrucellosis: Clinical and Diagnostic Features
Guven, T., Ugurlu, K., Ergonul, O., Celikbas, A. K., Gok, S. E., Comoglu, S., Baykam, N., & Dokuzoguz, B. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit072 · Cited by 248
Perez-Burgos, A., Wang, B., Mao, Y.-K., Mistry, B., Neufeld, K.-A. M., Bienenstock, J., & Kunze, W. (2013) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00128.2012 · Cited by 235
Microbiota Signaling Pathways that Influence Neurologic Disease
Cox, L. M., & Weiner, H. L. (2018) · Neurotherapeutics · doi:10.1007/s13311-017-0598-8 · Cited by 207
Oral and nasal microbiota in Parkinson's disease
Pereira, P. A. B., Aho, V. T. E., Paulin, L., Pekkonen, E., Auvinen, P., & Scheperjans, F. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.02.026 · Cited by 204
Van Maele-Fabry, G., Hoet, P., Vilain, F., & Lison, D. (2012) · Environment International · doi:10.1016/j.envint.2012.05.004 · Cited by 182
Ochoa-Cortes, F., Turco, F., Linan-Rico, A., Soghomonyan, S., Whitaker, E., Wehner, S., Cuomo, R., & Christofi, F. L. (2016) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000667 · Cited by 161
Domingo, A., & Klein, C. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-63233-3.00014-2 · Cited by 152
Validation of the non-motor symptoms questionnaire (NMS-Quest)
Romenets, S. R., Wolfson, C. M., Galatas, C., Pelletier, A., Altman, R., Wadup, L., & Postuma, R. B. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.08.013 · Cited by 150
Gough, E. K., Stephens, D. A., Moodie, E. E. M., Prendergast, A. J., Stoltzfus, R. J., Humphrey, J. H., & Manges, A. R. (2015) · Microbiome · doi:10.1186/s40168-015-0089-2 · Cited by 140
Submandibular gland needle biopsy for the diagnosis of Parkinson disease
Adler, C. H., Dugger, B. N., Hinni, M. L., Lott, D. G., Driver‐Dunckley, E. D., Hidalgo, J., Henry-Watson, J., Serrano, G. E., Sue, L. I., Nagel, T. H., et al. (2014) · Neurology · doi:10.1212/wnl.0000000000000204 · Cited by 140
Genetics of Parkinson’s Disease
(2007) · Parkinson's Disease · doi:10.3109/9781420019223-5 · Cited by 124
Development and testing of the Parkinson's disease quality of life scale
Welsh, M. D., McDermott, M., Holloway, R. G., Plumb, S., Pfeiffer, R. F., & Hubble, J. P. (2003) · Movement Disorders · doi:10.1002/mds.10424 · Cited by 123
The Yeast Complex I Equivalent NADH Dehydrogenase Rescues pink1 Mutants
Vilain, S., Esposito, G., Haddad, D., Schaap, O., Dobreva, M. P., Vos, M. H., Meensel, S. V., Morais, V. A., Strooper, B. D., & Verstreken, P. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002456 · Cited by 123
Bifidobacteria and humans: our special friends, from ecological to genomics perspectives
Ventura, M., Turroni, F., Lugli, G. A., & van Sinderen, D. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6356 · Cited by 111
Gustation assessment using the NIH Toolbox
Coldwell, S. E., Mennella, J. A., Duffy, V. B., Pelchat, M. L., Griffith, J. W., Smutzer, G., Cowart, B. J., Breslin, P. A. S., Bartoshuk, L. M., Hastings, L., et al. (2013) · Neurology · doi:10.1212/wnl.0b013e3182872e38 · Cited by 106
Bioconversion of l-tyrosine to l-DOPA by a novel bacterium Bacillus sp. JPJ
Surwase, S. N., & Jadhav, J. P. (2010) · Amino Acids · doi:10.1007/s00726-010-0768-z · Cited by 104
Activity‐dependent secretion of alpha‐synuclein by enteric neurons
Paillusson, S., Clairembault, T., Biraud, M., Neunlist, M., & Derkinderen, P. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12131 · Cited by 103
Measuring postural stability with an inertial sensor: validity and sensitivity
Neville, C., Ludlow, C., & Rieger, B. P. (2015) · Medical Devices Evidence and Research · doi:10.2147/mder.s91719 · Cited by 98
Self-citationUnger, M. M., Möller, J. C., Mankel, K., Eggert, K. M., Bohne, K., Bodden, M., Stiasny-Kolster, K., Kann, P. H., Mayer, G., Tebbe, J. J., et al. (2011) · Journal of Neurology · doi:10.1007/s00415-010-5864-1 · Cited by 97
Yu, S., Zhou, X., Li, F., Xu, C., Zheng, F. Y., Li, J., Zhao, H., Dai, Y., Liu, S., & Feng, Y. (2017) · Scientific Reports · doi:10.1038/s41598-017-00262-0 · Cited by 90
Adler, C. H., Dugger, B. N., Hentz, J. G., Hinni, M. L., Lott, D. G., Driver‐Dunckley, E. D., Mehta, S. H., Serrano, G. E., Sue, L. I., Duffy, A., et al. (2016) · Movement Disorders · doi:10.1002/mds.26476 · Cited by 89
Choi, D., & Choi, H. (2014) · Archives of Pharmacal Research · doi:10.1007/s12272-014-0503-5 · Cited by 75
Morley, J. F., Cohen, A. L., Silveira‐Moriyama, L., Lees, A. J., Williams, D. R., Katzenschlager, R., Hawkes, C. H., Shtraks, J. P., Weintraub, D. A., Doty, R. L., et al. (2018) · npj Parkinson s Disease · doi:10.1038/s41531-017-0039-8 · Cited by 73
Lastovica, A., On, S. L. W., & Zhang, L. (2014) · Springer eBooks · doi:10.1007/978-3-642-39044-9_274 · Cited by 66
Lathan, C., Spira, J. L., Bleiberg, J., Vice, J. M., & Tsao, J. W. (2013) · Military Medicine · doi:10.7205/milmed-d-12-00438 · Cited by 56
Nilsson, B. (1979) · Acta Odontologica Scandinavica · doi:10.3109/00016357909027585 · Cited by 53
Ainsworth, D., Sternberg, M. J. E., Raczy, C., & Butcher, S. (2016) · Nucleic Acids Research · doi:10.1093/nar/gkw1248 · Cited by 50
Pellegrini, C., Colucci, R., Antonioli, L., Barocelli, E., Ballabeni, V., Bernardini, N., Blandizzi, C., de Jonge, W. J., & Fornai, M. (2016) · Neurogastroenterology & Motility · doi:10.1111/nmo.12933 · Cited by 43
Executive Function and Postural Instability in People with Parkinson’s Disease
Xu, D. Q., Cole, M. H., Mengersen, K. L., Silburn, P. A., Qiu, F., Graepel, C. L., & Kerr, G. (2014) · Parkinson s Disease · doi:10.1155/2014/684758 · Cited by 34
Relationship Between Posturography, Clinical Balance and Executive Function in Parkinson´s Disease
Souza, C. D. O., Voos, M. C., Barbosa, A. F., Chen, J., Francato, D. C. V., Milosevic, M., Popović, M. R., Fonoff, E. T., Chien, H. F., & Barbosa, E. R. (2018) · Journal of Motor Behavior · doi:10.1080/00222895.2018.1458279 · Cited by 34
Apathy and Olfactory Dysfunction in Early Parkinson’s Disease
Hong, J. Y., Sunwoo, M. K., Ham, J. H., Lee, J. J., Lee, P. H., & Sohn, Y. H. (2015) · Journal of Movement Disorders · doi:10.14802/jmd.14029 · Cited by 31
Tobacco Use, Oral Health, and Risk of Parkinson's Disease
Liu, Z., Roosaar, A., Axéll, T., & Ye, W. (2016) · American Journal of Epidemiology · doi:10.1093/aje/kww146 · Cited by 29
The effects of dopamine on digit span in Parkinson’s disease
Warden, C., Hwang, J. J., Marshall, A. J., Fenesy, M. C., & Poston, K. L. (2016) · Journal of Clinical Movement Disorders · doi:10.1186/s40734-016-0033-z · Cited by 28
Parkinsonism in neurobrucellosis.
Molins, A., Montalbán, X., & Codina, A. (1987) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.50.12.1707-a · Cited by 20
Animal Models of Gastrointestinal Problems in Parkinson's Disease
Greene, J. G. (2011) · Journal of Parkinson s Disease · doi:10.3233/jpd-2011-11033 · Cited by 13
A case of brucellosis displaying Parkinsonian-like tremor
Jin, K., Liu, Y., Chen, N., Kong, L., Jiang, L., Li, J., & Huang, Z. (2013) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.3025 · Cited by 6
Oshima, K., Hayashi, J.-I., Toh, H., Nakano, A., Shindo, C., Komiya, K., Morita, H., Honda, K., & Hattori, M. (2015) · Genome Announcements · doi:10.1128/genomea.00485-15 · Cited by 6
Gut Hormones Restrict Neurodegeneration in Parkinson’s Disease
Bayliss, J., Stark, R., Reichenbach, A., & B., Z. (2011) · Advanced Understanding of Neurodegenerative Diseases · doi:10.5772/28028 · Cited by 5
Мин, Asano, KOHANAWA, & MINAGAWA (1999) · Immunology · doi:10.1046/j.1365-2567.1999.00659.x · Cited by 4
Cited by
Microbiota in health and diseases
Hou, K., Wu, Z.-X., Chen, X.-Y., Wang, J.-Q., Zhang, D., Xiao, C., Zhu, D., Koya, J. B., Wei, L., Li, J., et al. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00974-4 · Cited by 3,171
“In a cross-sectional case control design study on PD, around 16 bacterial families were found to be altered in early-stage PD patients.(284) Among them, variation in families like Bifidobacteriaceae, Saccharomycetaceae and Lactobacillaceae were studied extensively for their role in progression of PD.”
BackgroundThe role of gut dysbiosis in Parkinson’s disease: mechanistic insights and therapeutic options
Wang, Q., Luo, Y., Ray Chaudhuri, K., Reynolds, R., Tan, E.-K., & Pettersson, S. (2021) · Brain · doi:10.1093/brain/awab156 · Cited by 281
Progress in Oral Microbiome Related to Oral and Systemic Diseases: An Update
Lee, Y.-H., Chung, S. W., Auh, Q.-S., Hong, S.-J., Lee, Y.-A., Jung, J., Lee, G.-J., Park, H. J., Shin, S.-I., & Hong, J.-Y. (2021) · Diagnostics · doi:10.3390/diagnostics11071283 · Cited by 168
“Neurodegenerative disorders, such as Alzheimer’s disease [145] and Parkinson’s disease [146] have also been reported to be associated with the oral microbiome.”
BackgroundDiet in Parkinson’s Disease: Critical Role for the Microbiome
Jackson, A., Forsyth, C. B., Shaikh, M., Voigt, R. M., Engen, P. A., Ramirez, V., & Keshavarzian, A. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.01245 · Cited by 145
“The majority of PD human studies employed bacterial 16S ribosomal RNA (rDNA amplicons) sequencing to different variable regions to identify bacteria in feces (majority of studies), colonic sigmoid mucosa (98), nasal wash (105) or nasal swab and oral (106, 107) samples.”
BackgroundMethodEmerging role of the host microbiome in neuropsychiatric disorders: overview and future directions
Hashimoto, K. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02287-6 · Cited by 157
“Notably, the oral microbiota in early-stage PD patients shows signi fi cant differences compared to healthy controls, with speci fi c oral bacteria exhibiting associations with motor and non-motor functional measures [112].”
Background
Metadata
- Authors
- Mihaila, D., Donegan, J., Barns, S., LaRocca, D., Du, Q., Zheng, D., Vidal, M., Neville, C., Uhlig, R., & Middleton, F. A.
- Affiliations
- SUNY Upstate Medical University (US)
- Quadrant Biosciences (United States) (US)
- Corresponding author
- Middleton, Frank A.
- Venue
- PLOS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-06-27
- Volume
- 14
- Issue
- 6
- Pages
- e0218252
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6597068
- OpenAlex
- W2953419696
- Cited by
- 94
- References
- 76
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 11 · 2023: 17 · 2022: 20 · 2021: 13 · 2020: 12 · 2019: 2
- FWCI
- 13.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Quadrant Biosciences
- Topics
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- Parkinson's disease, oral microbiota, early-stage Parkinson's disease, saliva, microbial RNA, biomarkers, diagnostic biomarkers, metatranscriptomics, microbial metabolic pathways, amino acid metabolism, energy metabolism, motor function, non-motor functions, cognition, balance, autonomic function, chemosensory function, disease duration
- MeSH terms
- Aged, Bacteria, Cognition, Female, Humans, Male, Motor Activity, Mouth, Parkinson Disease, Phylogeny, Reaction Time, RNA, Messenger, ROC Curve, Saliva, Biodiversity, Gene Regulatory Networks, Metabolic Networks and Pathways, Microbiota
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.